Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. 22893105 Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H Cancer 2013 PLCO
Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial. 23065684 Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD Int. J. Cancer 2013 PLCO
An aggregated analysis of hormonal factors and endometrial cancer risk by parity. 23280123 Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV Cancer 2013 PLCO
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. 23112111 Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutr… Cancer Causes Control 2013 PLCO
Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. 23171878 Chaturvedi AK, Moore SC, Hildesheim A Am. J. Epidemiol. 2013 PLCO
Results of initial low-dose computed tomographic screening for lung cancer. 23697514 National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S N. Engl. J. Med. 2013 NLST
National lung screening trial: variability in nodule detection rates in chest CT studies. 23592767 Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J Radiology 2013 NLST
Selection criteria for lung-cancer screening. 23425165 Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD N. Engl. J. Med. 2013 NLST
Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up. 23280348 Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA Cancer 2013 NLST
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. 23513242 Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS Radiology 2013 NLST
Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: the model used by the American College of Radiology arm of the National Lung Screening Trial. 22982342 Gareen IF, Sicks JD, Jain AA, Moline D, Coffman-Kadish N Contemp Clin Trials 2013 NLST
Targeting of low-dose CT screening according to the risk of lung-cancer death. 23863051 Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA N. Engl. J. Med. 2013 NLST
Effective dose assessment for participants in the National Lung Screening Trial undergoing posteroanterior chest radiographic examinations. 23789668 Kruger R, Flynn MJ, Judy PF, Cagnon CH, Seibert JA AJR Am J Roentgenol 2013 NLST
The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. 24037918 Pinsky PF, Church TR, Izmirlian G, Kramer BS Cancer 2013 NLST
ROC curves for low-dose CT in the National Lung Screening Trial. 24009092 Pinsky PF, Gierada DS, Nath H, Kazerooni EA, Amorosa J J Med Screen 2013 NLST
Individual variations in serum melatonin levels through time: implications for epidemiologic studies. 24376664 Nogueira LM, Sampson JN, Chu LW, Yu K, Andriole G, Church T, Stanczyk FZ, Koshiol J, Hsing AW PLoS ONE 2013 PLCO
Telomere length and risk of glioma. 24231251 Walcott F, Rajaraman P, Gadalla SM, Inskip PD, Purdue MP, Albanes D, Orr E, De Vivo I, Savage SA Cancer Epidemiol 2013 PLCO
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. 24115361 Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK J. Natl. Cancer Inst. 2013 PLCO
Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. 23907431 Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J Br. J. Cancer 2013 PLCO
Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. 24089460 Mir MC, Stephenson AJ, Grubb RL, Black A, Kibel AS, Izmirlian G Cancer Epidemiol. Biomarkers Prev. 2013 PLCO